Targeting the Process of Farynesylation for Therapy of Hematologic Malignancies

E-ISSN： 1875-5666|5|7|643-652

ISSN： 1566-5240

Source： Current Molecular Medicine, Vol.5, Iss.7, 2005-11, pp. : 643-652

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Angiogenesis in hematologic malignancies

By Moehler T. Neben K. Ho A. Goldschmidt H.

Annals of Hematology, Vol. 80, Iss. 12, 2001-12 ,pp. : 695-705

Springer Publishing Company

Access to resources Recommend Favorite

Early hospital discharge with oral antimicrobial therapy in patients with hematologic malignancies and low-risk febrile neutropenia

By Girmenia Corrado Russo Eleonora Carmosino Ida Breccia Massimo Dragoni Francesco Latagliata Roberto Mecarocci Sergio Morano Salvatore Stefanizzi Caterina Alimena Giuliana

Annals of Hematology, Vol. 86, Iss. 4, 2007-04 ,pp. : 263-270

Springer Publishing Company

Access to resources Recommend Favorite

Intrathecal chemotherapy for hematologic malignancies: drugs and toxicities

By Kwong Yok-Lam

Annals of Hematology, Vol. 88, Iss. 3, 2009-03 ,pp. : 193-201

Springer Publishing Company

Access to resources Recommend Favorite

Hematologic malignancies associated with germ cell tumors

By Zhao Guang-Quan Dowell Jonathan E

Expert Review of Hematology, Vol. 5, Iss. 4, 2012-08 ,pp. : 427-437

Informa Healthcare

Access to resources Recommend Favorite

Kinases as Drug Discovery Targets in Hematologic Malignancies

Current Molecular Medicine, Vol. 5, Iss. 7, 2005-11 ,pp. : 625-642

Bentham Science Publishers

Access to resources Recommend Favorite